FDA Expands Marstacimab Indication in Hemophilia A and B
-
By
-
Kathryn Wighton
-
June 8, 2026
-
3 min
By
Kathryn Wighton
June 8, 2026
Clinical studies showed reductions in circulating thyroid hormone levels and changes in heart rate and systolic blood pressure.
September 29, 2026